Regulating High Consequence Pathogens and Toxins: Upgrading the Drug Coding System

February 01, 2007

In addition to the ineffective oversight of bulk biological agents and inadequate drug tracking in the us, the current drug coding system used for certain pharmaceuticals creates opacity at the point of use that could be detrimental to national security interests in tracking the origins and chain of custody for specific products. The potential use of biological agents and toxins to incite mass panic in the United States should motivate government officials to utilize all means available to track, trace and secure the movement of both raw toxin and prescription products.

Written by

  • Rita Grossman-Vermaas
    Senior Associate and Director of the Center for the Study of Threat Convergence at The Fund for Peace